Oa and Hypertrophic cardiomyopathy - from FDA reports


Hypertrophic cardiomyopathy is found among people with Oa, especially for people who are female, 60+ old, take medication Vioxx and have Dyslipidaemia. This review analyzes which people have Hypertrophic cardiomyopathy with Oa. It is created by eHealthMe based on reports of 16 people who have Oa from FDA , and is updated regularly.



{pitch.title}



On Jun, 24, 2018

16 people who have Oa and Hypertrophic Cardiomyopathy are studied.


Number of reports submitted per year:

Would you have Hypertrophic cardiomyopathy when you have Oa?

Gender of people who have Oa and experience Hypertrophic Cardiomyopathy *:

  • female: 81.25 %
  • male: 18.75 %

Age of people who have Oa and experience Hypertrophic Cardiomyopathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.25 %
  • 50-59: 12.5 %
  • 60+: 81.25 %

Top co-existing conditions for these people *:

  1. Type 1 Diabetes: 1 person, 6.25%
  2. Preventive Health Care: 1 person, 6.25%
  3. Oedema Peripheral (superficial swelling): 1 person, 6.25%
  4. High Blood Pressure: 1 person, 6.25%
  5. Dyslipidaemia (abnormal amount of lipids): 1 person, 6.25%

Most common drugs for these people *:

  1. Vioxx: 13 people, 81.25%
  2. Diovan: 12 people, 75.00%
  3. Cozaar: 11 people, 68.75%
  4. Celebrex: 2 people, 12.50%
  5. Vytorin: 1 person, 6.25%
Click here to get more results

Top symptoms for these people *:

  1. Heart Attack: 13 people, 81.25%
  2. Urinary Tract Infection: 13 people, 81.25%
  3. Cardiac Failure Congestive: 13 people, 81.25%
  4. Salivary Gland Disorder (disease of salivary gland): 12 people, 75.00%
  5. Cholecystitis (infection of gallbladder): 12 people, 75.00%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Do you have Hypertrophic cardiomyopathy with Oa?




Related studies


Oa

Oa (osteoarthritis /a joint disease caused by cartilage loss in a joint) can be treated by Celebrex, Meloxicam, Tramadol, Mobic, Naproxen (latest reports from 51,516 Oa patients)

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (a condition in which the heart muscle becomes abnormally thick) has been reported by people with high blood pressure, glycogen storage disease type ii, osteoporosis, neoplasm malignant, diabetes (latest reports from 1,549 Hypertrophic cardiomyopathy patients).


Drugs that are associated with Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (575 drugs)
Other conditions that could cause Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (563 conditions)
Browse all symptoms of Oa
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Oa, Hypertrophic cardiomyopathy

Recent updates

General studies
Active Support Groups
Recent Predictions
Care Guides wanted

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.